Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients

Abstract

Insights

Accurate identification of Pseudomonas aeruginosa in cystic fibrosis (CF) patients is crucial. A PCR method targeting the oprL gene effectively identifies P. aeruginosa morphotypes in CF patients.

Area of Science:

  • Medical Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is a significant pathogen in cystic fibrosis (CF) patients.
  • Identifying different morphotypes of P. aeruginosa is essential for understanding its adaptation and persistence in CF lungs.

Purpose of the Study:

  • To develop and validate a precise molecular method for identifying P. aeruginosa isolates from CF patients.
  • To differentiate P. aeruginosa at the species level using genus- and species-specific primers.

Main Methods:

  • Samples from 100 CF patients were cultured on cetrimide agar.
  • Suspected colonies underwent phenotypic screening for P. aeruginosa.
  • Molecular identification was performed using PCR with primers targeting the oprI (genus) and oprL (species) genes.

Main Results:

  • Phenotypic tests identified P. aeruginosa in 40% of CF patients.
  • Genus-specific primers (oprI) confirmed 40 isolates as fluorescent pseudomonads.
  • Species-specific primers (oprL) verified 37 of these isolates as P. aeruginosa.

Conclusions:

  • Species-specific PCR targeting the oprL gene is an accurate method for identifying P. aeruginosa in CF patients.
  • This PCR-based approach offers a simple and reliable way to identify diverse P. aeruginosa morphotypes in this population.